TipRanks
Go Ultimate55% OFF

Monte Rosa Therapeutics (GLUE) Cash flow

Monte Rosa Therapeutics Cash Flow

GLUE's free cash flow for Q2 2026 was $-48.84M. For the 2026 fiscal year, GLUE's free cash flow was decreased by $-4.72M and operating cash flow was $-44.11M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -22.80M$ 42.00M$ -43.80M$ -92.47M$ -59.36M
$ -101.83M$ -44.45M$ 88.80M$ -219.22M$ -9.65M
$ 30.35M$ 98.89M$ 27.49M$ 20.47M$ 377.56M
$ 134.84M$ 229.12M$ 132.68M$ 60.19M$ 351.41M
$ -27.50M$ 38.01M$ -62.84M$ -105.38M$ -69.09M

Currency in USD

Monte Rosa Therapeutics Cash Flow

-400M-200M0200M400M600M2019202020212022202320242025OperatingInvestingFinancing